A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
Clinical trial NCT02814175 · COMPLETED
Trial details
- NCT number
- NCT02814175
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-05
- Primary completion
- 2019-09-23
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.